Birdwatch Archive

Birdwatch Note

2024-03-31 09:13:12 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

小林製薬はワクチンの製造を断った、というのはデマです。 小林製薬が扱っている医薬品は一般消費者向けです。 元々ワクチンを製造しておらず、製造を断るという状況はあり得ません。 医療機関・医師への小林製薬の支払額の情報が出てこないのも同様の理由です。 小林製薬の医薬品一覧 https://www.qlife.jp/meds/maker/183/1/ 小林製薬 統合報告書2022.12 https://www.kobayashi.co.jp/ir/report/annualreport/pdf/KobayashiS_ar_2022_japanese_a3_4.pdf.pdf 小林製薬 2022年12月期 有価証券報告書 https://www.kobayashi.co.jp/ir/report/asr/pdf/2022_4yuho.pdf

Written by A71C7604A85D2B14280723049D0EF96C5A4BA60970EA8E9221AD0EDA5AC6FEC2
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1774255591374148020

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1774364309075706102
  • noteId - 1774364309075706102
  • participantId -
  • noteAuthorParticipantId - A71C7604A85D2B14280723049D0EF96C5A4BA60970EA8E9221AD0EDA5AC6FEC2 Participant Details
  • createdAtMillis - 1711876392035
  • tweetId - 1774255591374148020
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • 小林製薬はワクチンの製造を断った、というのはデマです。 小林製薬が扱っている医薬品は一般消費者向けです。 元々ワクチンを製造しておらず、製造を断るという状況はあり得ません。 医療機関・医師への小林製薬の支払額の情報が出てこないのも同様の理由です。 小林製薬の医薬品一覧 https://www.qlife.jp/meds/maker/183/1/ 小林製薬 統合報告書2022.12 https://www.kobayashi.co.jp/ir/report/annualreport/pdf/KobayashiS_ar_2022_japanese_a3_4.pdf.pdf 小林製薬 2022年12月期 有価証券報告書 https://www.kobayashi.co.jp/ir/report/asr/pdf/2022_4yuho.pdf

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-03-31 09:13:12 UTC
(1711876392035)
2024-03-31 17:40:33 UTC
(1711906833110)
CURRENTLY_RATED_HELPFUL 2024-04-01 03:14:14 UTC
(1711941254008)
CURRENTLY_RATED_HELPFUL 2024-03-31 17:40:33 UTC
(1711906833110)
CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2024-03-31 20:44:14 -0500 Rating Details
2024-03-31 20:43:35 -0500 Rating Details
2024-03-31 20:33:08 -0500 Rating Details
2024-03-31 20:20:18 -0500 Rating Details
2024-03-31 19:59:26 -0500 Rating Details
2024-03-31 19:12:47 -0500 Rating Details
2024-03-31 19:04:52 -0500 Rating Details
2024-03-31 19:01:28 -0500 Rating Details
2024-03-31 18:55:52 -0500 Rating Details
2024-03-31 18:50:26 -0500 Rating Details
2024-03-31 18:49:50 -0500 Rating Details
2024-03-31 18:09:05 -0500 Rating Details
2024-03-31 13:21:03 -0500 Rating Details
2024-03-31 11:47:22 -0500 Rating Details
2024-03-31 10:14:14 -0500 Rating Details
2024-03-31 08:16:23 -0500 Rating Details
2024-03-31 07:49:18 -0500 Rating Details
2024-03-31 06:08:46 -0500 Rating Details
2024-03-31 06:02:06 -0500 Rating Details
2024-03-31 05:46:30 -0500 Rating Details
2024-03-31 05:25:00 -0500 Rating Details
2024-03-31 05:07:49 -0500 Rating Details
2024-03-31 04:55:56 -0500 Rating Details
2024-03-31 04:45:41 -0500 Rating Details
2024-03-31 04:43:12 -0500 Rating Details
2024-03-31 04:43:03 -0500 Rating Details
2024-03-31 04:42:10 -0500 Rating Details
2024-03-31 04:42:09 -0500 Rating Details
2024-03-31 04:40:59 -0500 Rating Details
2024-03-31 04:39:55 -0500 Rating Details
2024-03-31 04:36:24 -0500 Rating Details
2024-03-31 04:35:39 -0500 Rating Details
2024-03-31 04:30:38 -0500 Rating Details
2024-03-31 04:30:13 -0500 Rating Details
2024-03-31 04:28:36 -0500 Rating Details
2024-03-31 04:28:35 -0500 Rating Details
2024-04-01 07:16:57 -0500 Rating Details
2024-04-01 04:02:35 -0500 Rating Details
2024-03-31 23:42:16 -0500 Rating Details
2024-03-31 22:53:25 -0500 Rating Details
2024-03-31 21:33:43 -0500 Rating Details
2024-03-31 21:15:58 -0500 Rating Details
2024-03-31 21:09:37 -0500 Rating Details
2024-03-31 20:26:15 -0500 Rating Details
2024-03-31 19:24:56 -0500 Rating Details
2024-03-31 18:49:46 -0500 Rating Details
2024-03-31 09:41:39 -0500 Rating Details
2024-03-31 08:42:11 -0500 Rating Details
2024-03-31 08:37:38 -0500 Rating Details
2024-03-31 07:46:35 -0500 Rating Details
2024-03-31 07:26:24 -0500 Rating Details
2024-03-31 07:21:10 -0500 Rating Details
2024-03-31 07:17:10 -0500 Rating Details
2024-03-31 07:15:12 -0500 Rating Details
2024-03-31 05:49:40 -0500 Rating Details
2024-03-31 05:41:17 -0500 Rating Details
2024-03-31 05:26:47 -0500 Rating Details
2024-03-31 05:25:30 -0500 Rating Details
2024-03-31 05:19:49 -0500 Rating Details
2024-03-31 05:13:56 -0500 Rating Details
2024-03-31 05:07:17 -0500 Rating Details
2024-03-31 05:06:01 -0500 Rating Details
2024-03-31 04:55:50 -0500 Rating Details
2024-03-31 04:53:56 -0500 Rating Details
2024-03-31 04:49:24 -0500 Rating Details
2024-03-31 04:49:00 -0500 Rating Details
2024-03-31 04:46:07 -0500 Rating Details
2024-03-31 04:38:35 -0500 Rating Details
2024-03-31 04:31:39 -0500 Rating Details
2024-03-31 04:31:06 -0500 Rating Details
2024-04-01 22:12:27 -0500 Rating Details
2024-03-31 17:59:27 -0500 Rating Details
2024-04-08 21:30:06 -0500 Rating Details
2024-04-01 06:12:52 -0500 Rating Details
2024-04-01 17:59:56 -0500 Rating Details
2024-04-01 16:52:54 -0500 Rating Details
2024-04-01 05:58:51 -0500 Rating Details
2024-04-01 04:22:53 -0500 Rating Details
2024-04-01 00:23:56 -0500 Rating Details
2024-03-31 22:12:42 -0500 Rating Details
2024-07-06 09:21:39 -0500 Rating Details